Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Aradigm reports topline results from ORBIT-3 and -4 studies of Pulmaquin

Dec. 2, 2016

Wistar Institute discloses EBNA-1 inhibitors

Dec. 2, 2016

Arsanis' ASN-100 receives FDA fast track designation

Dec. 2, 2016

Roche patent describes TLR7 agonists for HBV infections

Dec. 1, 2016

Tangrun Pharmaceuticals patents agents for HCV infection

Dec. 1, 2016

MicuRx Pharmaceuticals begins phase I study of MRX-4

Dec. 1, 2016

BiondVax's universal flu vaccine safe, well tolerated in phase II study

Dec. 1, 2016

A tetravalent vaccine candidate against lymphatic filariasis

Dec. 1, 2016

Walter Reed Army Institute of Research presents promising new malaria vaccine candidates

Nov. 30, 2016

Hetero Research Foundation patents antiviral agents

Nov. 29, 2016

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...